GSK signs shingles vaccine deal with Zhifei

Zhifei, China’s largest vaccine company, will pay UK drugmaker GSK $3.05 billion for exclusive distribution rights to GSK’s shingles vaccine in the world’s second-largest pharmaceutical market.

Share This Post:

POPULAR POSTS
FOLLOW US
Like Us On Facebook
Follow Us On Twitter
Subscribe To Our Channel
TikTok
LIVE STREAM